Research ArticleResearch

Oral Health Experiences of the Limited Scleroderma Patient

Krista L. Beaty, JoAnn R. Gurenlian and Ellen J. Rogo
American Dental Hygienists' Association August 2021, 95 (4) 59-69;

References

  1. 1.↵
    1. Kumar, V,
    2. Abbas, AK,
    3. Aster, JC. et al.
    Pathologic basis of disease. 9th ed. Philadelphia (PA): Elsevier Saunders; 2015. 228 p.
  2. 2.↵
    1. Albilia JB,
    2. Lam, DK,
    3. Blanas, N, et al.
    Small mouths… big problems? A review of scleroderma and its oral health implications. J Can Dent Assoc. 2007 Nov;73(9):831-8.
    OpenUrlPubMed
  3. 3.↵
    1. Chaffee NR.
    CREST syndrome: Clinical manifestations and dental management. J Prosthodont. 2005 Mar 21; 7(3):155-60.
    OpenUrl
  4. 4.
    1. Haustein UF.
    Systemic sclerosis: an update. Lab Med. 2011 Sep;42(9):562-72.
    OpenUrlCrossRef
  5. 5.↵
    1. Hunzelmann N,
    2. Genth E,
    3. Krieg W, et al.
    The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford). 2008 Aug; 47(8):1185-92.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.
    1. Shah AA,
    2. Wigley FM.
    My approach to the treatment of scleroderma. Mayo Clin Proc. 2013 Apr; 88(4):377-93.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Simeon-Aznar CP,
    2. Fonollosa-Pla V,
    3. Tolosa-Vilella C, et al.
    Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Semin Arthritis Rheum. 2012 Jun; 41(6):789-800.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Halachmi S,
    2. Gabari O,
    3. Cohen S, et al.
    Telangiectasias in CREST syndrome and systemic sclerosis: correlation of clinical and pathological features with response to pulsed dye laser treatment. Lasers Med Sci. 2014 Jan 14;29(1):137-40.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.
    1. Lauritano D,
    2. Bussolati A,
    3. Baldoni M, et al.
    Scleroderma and CREST syndrome: a case report in dentistry. Minerva Stomatol. 2011 Sep 1;60(9):443-65.
    OpenUrlPubMed
  10. 10.↵
    1. Yoon JC.
    CREST syndrome. Medscape [internet]. New York: Medscape, LLC; 1994-2021 [cited 2019 Jun 26]. Available from: https://emedicine.medscape.com/article/1064663-overview.
  11. 11.↵
    1. Ganda K.
    Dentist’s guide to medical conditions and complications. 2nd ed. Ames, IA: John Wiley & Sons; 2013. 792 p.
  12. 12.↵
    1. Silman AJ.
    Epidemiology of scleroderma. Curr Opin Rheumoatol. 1991 Nov;3(6):967-72.
    OpenUrl
  13. 13.
    1. Chifflot, H,
    2. Fautrel, B,
    3. Sordet, C, et al.
    Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008 Feb;37(4):223-35.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Barnes, J,
    2. Mayes, MD.
    Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012, 24:165–70.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Knaś M,
    2. Zalewska A,
    3. Waszkiewicz N, et al.
    Salivary flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis. J Oral Pathol Med. 2014 Feb 12;43(7), 521–9.
    OpenUrl
  16. 16.↵
    1. Zian Z,
    2. Bakkach J,
    3. Barakat A, et al.
    Salivary biomarkers in systemic sclerosis disease. Biomed Res Int. 2018 Mar 12;3921247: 1-7
    OpenUrl
  17. 17.↵
    1. Alantar A,
    2. Cabane J,
    3. Hachulla E, et al.
    Recommendations for the care of oral involvement in patients with systemic sclerosis. Arthritis Care Res. 2011 Apr 11;63(8):1126-33.
    OpenUrlCrossRefWeb of Science
  18. 18.↵
    1. Tolle SL.
    Scleroderma: considerations for dental hygienists. Int J Dent Hyg. 2008 Apr 10;6(2):77-83.
    OpenUrlPubMed
  19. 19.↵
    1. Pizzo G,
    2. Scardina GA,
    3. Messina P.
    Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003 Jul 9;7(3):175-8.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Fischer DJ,
    2. Patton LL.
    Scleroderma: oral manifestations and treatment challenges. Spec Care Dentist. 2000 Mar 12; 20(6):240-4.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Hudson M,
    2. Thombs BD,
    3. Steele R, et al.
    Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Care Res. 2009 Aug 15 61(8), 1112-20.
    OpenUrl
  22. 22.↵
    1. Bennadi D &
    2. Reddy CVK.
    Oral health related quality of life. J Int Soc Prev Community Dent, 2013 Jan-Jun 3(1), 1–6.
    OpenUrlPubMed
  23. 23.↵
    1. Baron M,
    2. Hudson M,
    3. Tatibouet S, et al.
    The Canadian systemic sclerosis oral health study: orofacial manifestations and oral health-related quality of life in systemic sclerosis compared with the general population. Rheumatology (Oxford), 2014 Aug 53(8), 1386-94.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Baron M,
    2. Hudson M,
    3. Tatibouet S, et al.
    The Canadian systemic sclerosis oral health study II: the relationship between oral and global health-related quality of life in systemic sclerosis. Rheumatology (Oxford). 2015 Oct 6 54(4), 692-6.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Leon, L,
    2. Abasolo, L,
    3. Redondo, M, et al.
    Negative affect in systemic sclerosis. Rheumatol Int, 2014 Jun 11 34(5), 597-604.
    OpenUrl
  26. 26.↵
    1. Baron, M,
    2. Hudson, M,
    3. Tatibouet, S, et al.
    Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian systemic sclerosis oral health study III. Arthritis Care Res, 2015 Oct 09 67(5), 681-90.
    OpenUrl
  27. 27.↵
    1. Pokrajac-Zirojevic V,
    2. Slack-Smith LM,
    3. Booth D.
    Arthritis and use of dental services: a population-based study. Aust Dent J. 2008 Mar 12; 47(3):208-13.
    OpenUrl
  28. 28.↵
    1. Suarez-Almazor ME,
    2. Kallen MA,
    3. Roundtree AK, et al.
    Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol. 2007 Aug; 34(8):1718-26.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Slade GD,
    2. Spencer AJ.
    Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994 Mar 1;11(1):3-11.
    OpenUrlPubMed
  30. 30.↵
    1. Slade GD.
    Derivation and validation of a short-form Oral Health Impact Profile. Community Dent Oral Epidemiol. 2006 May 29;25(4):284-90.
    OpenUrl
  31. 31.↵
    1. Mouthon L,
    2. Rannou F,
    3. Bérezné A, et al.
    Development and validation of a scale for mouth handicap in systemic sclerosis: the Mouth Handicap in systemic sclerosis scale. Ann Rheum Dis. 2007 Dec 01; 66(12), 1651-5.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Maddali-Bongi S,
    2. Landi G,
    3. Galluccio F, et al.
    The rehabilitation of facial involvement in systemic sclerosis: efficacy of the combination of connective tissue massage, Kabat’s technique and kinesiotherapy: a randomized controlled trial. Rheumatol Int. 2010 Mar 18; 31(7):895-901.
    OpenUrl
  33. 33.↵
    1. Merriam SB,
    2. Tisdell, EJ.
    Qualitative research: A guide to design and implementation. 4th ed. Hoboken, NJ: Jossey-Bass; 2015. 346 p.
  34. 34.↵
    1. Mattsson M,
    2. Bostrom C,
    3. Mihai C, et al.
    Personal factors in systemic sclerosis and their coverage by patient-reported outcome measures: a multicenter European qualitative study and literature review. Eur J Phys Rehabil Med. 2015 Jan 9; 51(4):405-21.
    OpenUrl
  35. 35.↵
    1. Patel MR,
    2. Shah KS,
    3. Shallcross ML.
    A qualitative study of physician perspectives of cost-related communication and patients’ financial burden with managing chronic disease. BMC Health Serv Res. 2015 Nov 18;15(1):1.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Beaty, KL,
    2. Gurenlian, JR.
    Treating patients with CREST Syndrome. Dimens Dent Hyg. 2016 Feb; 14(02), 49-52.
    OpenUrl
  37. 37.
    1. Tolle, SL.
    Treatment planning for patients with scleroderma. Dimens Dent Hyg. 2012 Sep; 10(9), 50-3.
    OpenUrl
  38. 38.↵
    1. Yuen, H.K,
    2. Marlow, NM,
    3. Reed, SG, et al.
    Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil, 2012 Nov; 34(1), 84-9.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Cinar FI,
    2. Unver V,
    3. Yilmaz S, et al.
    Living with scleroderma: patients’ perspectives, a phenomenological study. Rheumatol Int. 2012 Nov; 32(11), 3573-9.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Kocher A,
    2. Adler S,
    3. Spichiger E.
    Skin and mucosa care in systemic sclerosis–patients’ and family caregivers’ experiences and expectations of a specific education programme: a qualitative study. Musculoskeletal care. 2013 Sep;11(3), 168-78.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Oral Health Experiences of the Limited Scleroderma Patient
Krista L. Beaty, JoAnn R. Gurenlian, Ellen J. Rogo
American Dental Hygienists' Association Aug 2021, 95 (4) 59-69;
del.icio.us logo Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords